Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
What sector does Wakamoto Pharmaceutical Co Ltd (4512) operate in?
Wakamoto Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Wakamoto Pharmaceutical Co Ltd (4512) current stock price?
As of the latest data, Wakamoto Pharmaceutical Co Ltd stock price is ¥290, with a previous close of ¥289. Wakamoto Pharmaceutical Co Ltd gained ¥1 in the last trading session, representing a 0.35% increase.
What is Wakamoto Pharmaceutical Co Ltd (4512) current market capitalization?
Wakamoto Pharmaceutical Co Ltd market cap is approximately 10.06 billion.
What is Wakamoto Pharmaceutical Co Ltd (4512) Earnings Per Share (EPS)?
The trailing EPS is ¥2.
What is Wakamoto Pharmaceutical Co Ltd (4512) Price-to-Earnings (P/E) ratio?
Wakamoto Pharmaceutical Co Ltd current P/E ratio is 156.76.
What is Wakamoto Pharmaceutical Co Ltd (4512) EBITDA?
Wakamoto Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 251.65 million.
Does Wakamoto Pharmaceutical Co Ltd (4512) pay dividends?
Yes. Wakamoto Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 1.03% and an estimated annual payout of ¥3 per share.
When is the next ex-dividend date for Wakamoto Pharmaceutical Co Ltd (4512)?
The next ex-dividend date is scheduled for March 28, 2026.
When is Wakamoto Pharmaceutical Co Ltd (4512) next earnings report?
Wakamoto Pharmaceutical Co Ltd is expected to release its next earnings report on June 30, 2025.
What is Wakamoto Pharmaceutical Co Ltd (4512) beta (volatility) score?
Wakamoto Pharmaceutical Co Ltd has a beta of 0.589, indicating lower volatility than the overall market.